77 related articles for article (PubMed ID: 16857107)
1. [Gastro-intestinal stromal tumours (GISTs): prognostic and therapeutic features].
Ferrarese F; Cecere V
G Chir; 2006 May; 27(5):205-8. PubMed ID: 16857107
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal stromal tumours: clinical and therapeutic features. A report of 25 cases].
Bdioui H; Jouini M; Bouzaiene H; Nouira K; Fteriche F; Ksantini R; Chebbi F; Kacem MJ; Ben Safta Z
Tunis Med; 2006 Oct; 84(10):599-602. PubMed ID: 17193848
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors (GISTs): a pathology view point.
Sornmayura P
J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254
[TBL] [Abstract][Full Text] [Related]
4. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
5. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP
Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal stromal tumours: a broad spectrum of clinical presentations].
Pacelli F; Rosa F; Papa V; Tortorelli AP; Sanchez AM; Covino M; Sofo L; Doglietto GB
Chir Ital; 2007; 59(6):771-9. PubMed ID: 18360981
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gastrointestinal stromal tumors--initial experience.
Lupaşcu C; Andronic D; Moldovanu R; Târcoveanu E; Georgescu S; Ferariu D
Chirurgia (Bucur); 2010; 105(5):657-62. PubMed ID: 21141090
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumours. Is aggressive surgical treatment reasonable in locally advanced cases?
Ascenzi P; Orienti L; Okoro U; Raspanti A; Ucchino G
Chir Ital; 2009; 61(5-6):559-64. PubMed ID: 20380258
[TBL] [Abstract][Full Text] [Related]
12. Gastric GISTs. Personal experience.
Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
[TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal stromal tumour: our experience].
Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
[TBL] [Abstract][Full Text] [Related]
14. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
Yoon SS; Tanabe KK
Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
[No Abstract] [Full Text] [Related]
15. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
16. A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era.
Reece-Smith AM; MacGoey P; Shah MA; Leeder P; Andrew DR; McCulloch T; Parsons SL
Eur J Surg Oncol; 2012 Jun; 38(6):484-9. PubMed ID: 22342866
[TBL] [Abstract][Full Text] [Related]
17. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
18. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
Renouf DJ; Wilson L; Blanke CD
Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours.
Bümming P; Ahlman H; Andersson J; Meis-Kindblom JM; Kindblom LG; Nilsson B
Br J Surg; 2006 Jul; 93(7):836-43. PubMed ID: 16705644
[TBL] [Abstract][Full Text] [Related]
20. Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience.
Wong DW; Lupton SC; Bhatt L; Gross L; Tanière P; Peake DR; Spooner D; Geh JI
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):517-22. PubMed ID: 18514495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
